Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,360,772
  • Shares Outstanding, K 84,520
  • Annual Sales, $ 19,390 K
  • Annual Income, $ -71,660 K
  • 36-Month Beta 3.15
  • Price/Sales 69.09
  • Price/Cash Flow N/A
  • Price/Book 7.10

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.55 +31.47%
on 11/14/17
18.40 -10.33%
on 12/04/17
+3.60 (+27.91%)
since 11/13/17
3-Month
11.30 +46.02%
on 10/26/17
18.40 -10.33%
on 12/04/17
+3.10 (+23.13%)
since 09/13/17
52-Week
2.85 +478.95%
on 12/28/16
18.40 -10.33%
on 12/04/17
+13.25 (+407.69%)
since 12/13/16

Most Recent Stories

More News
These 5 Stocks Have Popped More Than 100% Since Trump's Win

With tax cuts close to becoming law, it makes sense to pick stocks that have posted stellar performances since Trump's win.

SGMO : 16.50 (+2.48%)
SEDG : 36.55 (+1.25%)
RH : 100.84 (+4.09%)
TREE : 325.60 (+4.14%)
RXDX : 15.95 (+2.57%)
Today's Research Reports on Trending Tickers: Inovio Pharmaceuticals and Sangamo Therapeutics

NEW YORK, NY / ACCESSWIRE / December 13, 2017 / The Dow and the S&P 500 closed at new record highs on Tuesday as the Federal Reserve's two-day policy meeting kicked off. The Dow Jones Industrial Average...

SGMO : 16.50 (+2.48%)
INO : 4.46 (+4.94%)
Sangamo Announces European Medicines Agency Recommendation Of Orphan Medicinal Product Designation For Investigational Genome Editing Treatments For MPS I And MPS II

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has issued a positive opinion on the application for orphan...

SGMO : 16.50 (+2.48%)
The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics

The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia Therapeutics, Calithera Biosciences and GlycoMimetics

SGMO : 16.50 (+2.48%)
SRPT : 54.09 (+1.98%)
AKBA : 15.54 (+1.50%)
CALA : 8.75 (-1.69%)
GLYC : 16.47 (+0.12%)
Detailed Research: Economic Perspectives on Splunk, Sangamo Therapeutics, Williams-Sonoma, Coherent, Xenia Hotels & Resorts, and Career Education -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Splunk Inc. (NASDAQ:SPLK),...

SGMO : 16.50 (+2.48%)
WSM : 52.30 (+2.75%)
CECO : 12.35 (-1.52%)
XHR : 22.07 (+2.60%)
COHR : 290.80 (+1.39%)
SPLK : 80.44 (+0.34%)
5 Top-Ranked Drug Stocks that are Broker Favorites

With the pharma and biotech sector bouncing back in 2017, here is a look at five drug stocks including Sarepta (SRPT) that are broker favorites.

SGMO : 16.50 (+2.48%)
SRPT : 54.09 (+1.98%)
AKBA : 15.54 (+1.50%)
INCY : 98.10 (+2.83%)
CALA : 8.75 (-1.69%)
PFE : 36.64 (+0.16%)
GLYC : 16.47 (+0.12%)
4 Biotech Stocks to Better Your Financial Health This Winter

The biotech industry shows a solid performance so far this year except for a brief slump in between of late. However, it is a good idea to select stocks from a sector that is fundamentally strong.

SGMO : 16.50 (+2.48%)
XOMA : 33.83 (+5.59%)
SRPT : 54.09 (+1.98%)
EBS : 46.08 (+1.32%)
Is GW Pharma (GWPH) Likely to Beat Earnings Estimates in Q4?

GW Pharma (GWPH) will report its fiscal fourth-quarter results next week. Investors focus is expected to be on commercialization plan for Epidiolex.

SGMO : 16.50 (+2.48%)
LGND : 137.38 (+1.16%)
CATB : 1.74 (+2.35%)
GWPH : 123.98 (+1.36%)
Sangamo Therapeutics, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) announced today that the Compensation Committee of the Company's Board of Directors approved the grant effective on November 22, 2017 of inducement stock options...

SGMO : 16.50 (+2.48%)
Featured Company News - Sangamo Announced Treatment of First Patient in Phase-1/2 Clinical Trial Evaluating In Vivo Genome Editing Therapy for MPS II

Research Desk Line-up: Amicus Therapeutics Post Earnings Coverage

SGMO : 16.50 (+2.48%)
FOLD : 13.00 (+0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

2nd Resistance Point 17.30
1st Resistance Point 16.90
Last Price 16.50
1st Support Level 16.07
2nd Support Level 15.65

See More

52-Week High 18.40
Last Price 16.50
Fibonacci 61.8% 12.46
Fibonacci 50% 10.63
Fibonacci 38.2% 8.79
52-Week Low 2.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.